Forskning
Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital
Udgivet

Maternal obesity and metabolic disorders associate with congenital heart defects in the offspring: A systematic review

Publikation: Bidrag til tidsskriftReviewpeer review

  1. Genetic markers of abdominal obesity and weight loss after gastric bypass surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Breech and induction. Time for evidence-based informed consent

    Publikation: Bidrag til tidsskriftLetterpeer review

  2. The Role of Leptin in Fetal Growth during Pre-Eclampsia

    Publikation: Bidrag til tidsskriftReviewpeer review

  3. Continuing decline in the prevalence of cerebral palsy in Denmark for birth years 2008–2013

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Gitte Hedermann
  • Paula L Hedley
  • Ida N Thagaard
  • Lone Krebs
  • Charlotte Kvist Ekelund
  • Thorkild I A Sørensen
  • Michael Christiansen
Vis graf over relationer

BACKGROUND: Congenital heart defects (CHDs) are the most common congenital malformations. The aetiology of CHDs is complex. Large cohort studies and systematic reviews and meta-analyses based on these have reported an association between higher risk of CHDs in the offspring and individual maternal metabolic disorders such as obesity, diabetes, hypertension, and preeclampsia, all conditions that can be related to insulin resistance or hyperglycaemia. However, the clinical reality is that these conditions often occur simultaneously. The aim of this review is, in consequence, both to evaluate the existing evidence on the association between maternal metabolic disorders, defined as obesity, diabetes, hypertension, preeclampsia, dyslipidaemia and CHDs in the offspring, as well as the significance of combinations, such as metabolic syndrome, as risk factors.

METHODS: A systematic literature search of papers published between January 1, 1990 and January 14, 2021 was conducted using PubMed and Embase. Studies were eligible if they were published in English and were case-control or cohort studies. The exposures of interest were maternal overweight or obesity, hypertension, preeclampsia, diabetes, dyslipidaemia, and/or metabolic syndrome, and the outcome of interest was CHDs in the offspring. Furthermore, the studies were included according to a quality assessment score.

RESULTS: Of the 2,250 identified studies, 32 qualified for inclusion. All but one study investigated only the individual metabolic disorders. Some disorders (obesity, gestational diabetes, and hypertension) increased risk of CHDs marginally whereas pre-gestational diabetes and early-onset preeclampsia were strongly associated with CHDs, without consistent differences between CHD subtypes. A single study suggested a possible additive effect of maternal obesity and gestational diabetes.

CONCLUSIONS: Future studies of the role of aberrations of the glucose-insulin homeostasis in the common aetiology and mechanisms of metabolic disorders, present during pregnancy, and their association, both as single conditions and-particularly-in combination, with CHDs are needed.

OriginalsprogEngelsk
Artikelnummere0252343
TidsskriftPLoS One
Vol/bind16
Udgave nummer5
Sider (fra-til)1-22
Antal sider22
ISSN1932-6203
DOI
StatusUdgivet - 27 maj 2021

ID: 65796367